Le Lézard
Classified in: Health
Subject: SVY

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017

LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary

Download the full report: https://www.reportbuyer.com/product/3984749

GlobalData's Medical Devices sector report, "Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Drug Delivery Infusion Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Delivery Infusion Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

- Extensive coverage of the Drug Delivery Infusion Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Drug Delivery Infusion Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Drug Delivery Infusion Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/3984749

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

These press releases may also interest you

at 07:03
NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services, announced today the appointment of George Cardoza as President of the Pharma Services Division and Sharon Virag as Chief Financial Officer. Ms. Virag will succeed...

at 07:03
Oncolytics Biotech® Inc. , a biotech company developing REOLYSIN® (pelareorep), an intravenously delivered immuno-oncolytic virus creating an inflamed phenotype, today announced that Grey Wilkinson, Ph.D., scientist of Translational Medicine at...

at 07:03
Trillium Therapeutics Inc. , an immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted an Orphan Drug...

at 07:00
Cipher Pharmaceuticals Inc. and Cardiome Pharma Corp. , today announced their entry into a definitive arrangement agreement pursuant to which Cipher will acquire the Canadian business portfolio of...

at 07:00
Boston Scientific Corporation announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain. The data demonstrated the...

at 07:00
Cressey & Company LP ("Cressey & Company" or the "Firm"), a healthcare-focused private investment firm, has announced that Andy Hurd, an experienced healthcare and technology executive, has joined the Firm as an Operating Partner. Mr. Hurd's...

News published on 6 october 2017 at 09:05 and distributed by: